Physician profile
Scott Thornton
NPI 1750351995
$3,672.47
in general payments reported to CMS, 2019-2025
7 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,623 · 2020: $28.16 · 2022: $21.38.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $3,437.13 | 2019 | |
| Braintree Laboratories, INC. | $159.96 | 2019 | |
| Boston Scientific Corporation | $21.38 | 2022 | |
| Baudax Bio INC. | $15.59 | 2020 | |
| Mallinckrodt Enterprises LLC | $13.53 | 2019 | |
| Portola Pharmaceuticals, LLC | $12.57 | 2020 | |
| Pacira Pharmaceuticals Incorporated | $12.31 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Scott Thornton listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.